Correspondence: serum neutralization of SARS-CoV-2 Omicron sublineages BA.1, BA.2 and BA.5 in lung transplant recipients receiving prophylactic tixagevimab/cilgavimab

被引：0
|
作者：
Eldin, Carole [1 ,2 ]
Nurtop, Elif [1 ]
Coiffard, Benjamin [3 ,4 ]
Colombini, Nathalie [5 ]
Ninove, Laetitia [1 ]
Priet, Stephane [1 ]
Barthelemy, Karine [1 ]
Reynaud-Gaubert, Martine [3 ,4 ]
de Lamballerie, Xavier [1 ]
机构：
[1] Aix Marseille Univ, Unite Virus Emergents, IRD 190, Inserm 1207,IRBA,Univ Corsica, Marseille, France
[2] Hop Nord Marseille, AP HP, Equipe Operat Hyg EOH, Com Lutte Contre Infect Nosocomiales CLIN, Marseille, France
[3] HM Hop Nord, Ctr Ressources & Competences Mucoviscidose CRCM Ad, Serv Pneumol & Equipe Transplantat Plum, AP HM, F-13015 Marseille, France
[4] Aix Marseille Univ, Marseille, France
[5] Aix Marseille Univ, North Hosp, Publ Hosp Marseille, Pharm Dept, Marseille, France
来源：
INFECTION | 2024年
关键词：
D O I：
10.1007/s15010-024-02258-1
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1697 / 1700
页数：4
相关论文
共 50 条
  • [31] Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
    Elliott, Paul
    Eales, Oliver
    Steyn, Nicholas
    Tang, David
    Bodinier, Barbara
    Wang, Haowei
    Elliott, Joshua
    Whitaker, Matthew
    Atchison, Christina
    Diggle, Peter J.
    Page, Andrew J.
    Trotter, Alexander J.
    Ashby, Deborah
    Barclay, Wendy
    Taylor, Graham
    Ward, Helen
    Darzi, Ara
    Cooke, Graham S.
    Donnelly, Christl A.
    Chadeau-Hyam, Marc
    SCIENCE, 2022, 376 (6600) : 1432 - +
  • [32] Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
    Takatsuki, Yuna
    Takahashi, Yuta
    Nakajima, Jun
    Iwasaki, Yumi
    Nagano, Katsutoshi
    Tani-Sassa, Chihiro
    Yuasa, Sonoka
    Kanehira, Saki
    Sonobe, Kazunari
    Nukui, Yoko
    Takeuchi, Hiroaki
    Tanimoto, Kousuke
    Tanaka, Yukie
    Kimura, Akinori
    Ichimura, Naoya
    Tohda, Shuji
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (02)
  • [33] A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Zhe Chen
    Leilei Feng
    Lei Wang
    Li Zhang
    Binyang Zheng
    Hua Fu
    Fengdi Li
    Ligai Liu
    Qi Lv
    Ran Deng
    YanLi Xu
    Yongfeng Hu
    Jianhua Zheng
    Chuan Qin
    Linlin Bao
    Xiangxi Wang
    Qi Jin
    Signal Transduction and Targeted Therapy, 10 (1)
  • [34] Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
    Kimura, Izumi
    Yamasoba, Daichi
    Tamura, Tomokazu
    Nao, Naganori
    Suzuki, Tateki
    Oda, Yoshitaka
    Mitoma, Shuya
    Ito, Jumpei
    Nasser, Hesham
    Zahradnik, Jiri
    Uriu, Keiya
    Fujita, Shigeru
    Kosugi, Yusuke
    Wang, Lei
    Tsuda, Masumi
    Kishimoto, Mai
    Ito, Hayato
    Suzuki, Rigel
    Shimizu, Ryo
    Begum, Mst Monira
    Yoshimatsu, Kumiko
    Kimura, Kanako Terakado
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Kobiyama, Kouji
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Shirakawa, Kotaro
    Takaori-Kondo, Akifumi
    Kuramochi, Jin
    Schreiber, Gideon
    Ishii, Ken J.
    Hashiguchi, Takao
    Ikeda, Terumasa
    Saito, Akatsuki
    Fukuhara, Takasuke
    Tanaka, Shinya
    Matsuno, Keita
    Sato, Kei
    CELL, 2022, 185 (21) : 3992 - +
  • [35] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Tseng, Hung Fu
    Ackerson, Bradley K.
    Bruxvoort, Katia J.
    Sy, Lina S.
    Tubert, Julia E.
    Lee, Gina S.
    Ku, Jennifer H.
    Florea, Ana
    Luo, Yi
    Qiu, Sijia
    Choi, Soon Kyu
    Takhar, Harpreet S.
    Aragones, Michael
    Paila, Yamuna D.
    Chavers, Scott
    Talarico, Carla A.
    Qian, Lei
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [36] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Hung Fu Tseng
    Bradley K. Ackerson
    Katia J. Bruxvoort
    Lina S. Sy
    Julia E. Tubert
    Gina S. Lee
    Jennifer H. Ku
    Ana Florea
    Yi Luo
    Sijia Qiu
    Soon Kyu Choi
    Harpreet S. Takhar
    Michael Aragones
    Yamuna D. Paila
    Scott Chavers
    Carla A. Talarico
    Lei Qian
    Nature Communications, 14
  • [37] Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
    Pedersen, Rune M.
    Bang, Line L.
    Madsen, Lone W.
    Sydenham, Thomas V.
    Johansen, Isik S.
    Jensen, Thoger G.
    Justesen, Ulrik S.
    Andersen, Thomas E.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1274 - 1275
  • [38] Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5
    Tuyji-Tok, Yesim
    Yucebag, Ebru
    Keles, Ayse Betul
    Kilincarslan, Ayse Ceylan
    Nohut, Okan Kadir
    Salman-Yilmaz, Seda
    Kuskucu, Mert Ahmet
    Midilli, Kenan
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 192 - 198
  • [39] Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
    Arora, Prerna
    Zhang, Lu
    Rocha, Cheila
    Sidarovich, Anzhalika
    Kempf, Amy
    Schulz, Sebastian
    Cossmann, Anne
    Manger, Bernhard
    Baier, Eva
    Tampe, Bjoern
    Moerer, Onnen
    Dickel, Steffen
    Dopfer-Jablonka, Alexandra
    Jaeck, Hans-Martin
    Behrens, Georg M. N.
    Winkler, Martin S.
    Poehlmann, Stefan
    Hoffmann, Markus
    LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 766 - 767
  • [40] Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
    Yang Yang
    Xiaohua Gong
    Jun Wang
    Shisong Fang
    Jiaqi Zhang
    Xuejiao Liao
    Yuan Guan
    Weihua Wu
    Yingxia Liu
    Hongzhou Lu
    Signal Transduction and Targeted Therapy, 7
12345